ArticleImmunotherapy advances2025
GLUT5 armouring enhances adoptive T-cell therapy anti-tumour activity under glucose-limiting conditions.
Robert Page et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it